Development and immunohistochemical characterization of patient-derived xenograft models for muscle invasive bladder cancer

OBJECTIVE(S): Patient-derived xenograft (PDX) models have become a valuable tool to evaluate chemotherapeutics and investigate personalized cancer treatment options. The role of PDXs in the study of bladder cancer, especially for improvement of novel targeted therapies, continues to expand. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Razzaghdoust, Abolfazl, Muhammadnejad, Samad, Parvin, Mahmoud, Mofid, Bahram, Zangeneh, Masoumeh, Basiri, Abbas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976898/
https://www.ncbi.nlm.nih.gov/pubmed/35432811
http://dx.doi.org/10.22038/IJBMS.2021.59943.13305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976898/
https://www.ncbi.nlm.nih.gov/pubmed/35432811
http://dx.doi.org/10.22038/IJBMS.2021.59943.13305

Ejemplares similares